Anuh Pharma Ltd NSE:ANUHPHR:
ANUH PHARMA LTD - GRANTED CERTIFICATE OF SUITABILITY FROM EDQM FOR SULFADIMETHOXINE
Anuh Pharma Granted Certificate Of Suitability From EDQM For Sulfadimethoxine
Earlier from Anuh Pharma
- ANUHPHR: Revenue increased but net profit fell; bonus shares issued and governance policies updated
- ANUHPHR: Sequential revenue and profit decline offset by year-over-year growth and leadership addition
- ANUHPHR: Net profit declined despite revenue growth; 1: 1 bonus issue and 30% dividend proposed
- ANUHPHR: Revenue and profit declined in Q3 FY25, with EBITDA margin at 9.86%